Evidence map›Paper›PMID 32759169›Full record

ArticleMolecular & cellular proteomics : MCP2020

Asparagine Hydroxylation is a Reversible Post-translational Modification.

Javier Rodriguez, Cameron D Haydinger, Daniel J Peet, Lan K Nguyen, Alex von Kriegsheim

Open access · hybridAbstract read
In one paragraph

Article in Molecular & cellular proteomics : MCP, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
1.3field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 19 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Review
  6. Review
  7. Review
  8. Review
  9. Matrisome changes in Parkinson's disease.Analytical and bioanalytical chemistry · 2022
    Article
  10. Review
  11. Review
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 4 institutions in 3 countries.

Javier RodriguezCancer Research UK Edinburgh Centre, University of Edinburgh, Edinburgh, UK; Systems Biology Ireland, University College Dublin, Dublin, Ireland.
Cameron D HaydingerSchool of Biological Sciences, University of Adelaide, Adelaide, Australia.
Daniel J PeetSchool of Biological Sciences, University of Adelaide, Adelaide, Australia.
Lan K NguyenDepartment of Biochemistry and Molecular Biology, Biomedicine Discovery Institute, Monash University, Melbourne, Australia.
Alex von KriegsheimCancer Research UK Edinburgh Centre, University of Edinburgh, Edinburgh, UK. Electronic address: alex.vonkriegsheim@IGMM.ed.ac.uk.
The University of Adelaide · AUAustralian Regenerative Medicine Institute · AUEdinburgh Cancer Research · GBUniversity College Dublin · IE

Funding

Cancer Research UK C157/A255140Wellcome TrustWellcome Trust 208402/Z/17/Z
6 · The paper itself

Abstract

Amino acid hydroxylation is a common post-translational modification, which generally regulates protein interactions or adds a functional group that can be further modified. Such hydroxylation is currently considered irreversible, necessitating the degradation and re-synthesis of the entire protein to reset the modification. Here we present evidence that the cellular machinery can reverse FIH-mediated asparagine hydroxylation on intact proteins. These data suggest that asparagine hydroxylation is a flexible and dynamic post-translational modification akin to modifications involved in regulating signaling networks, such as phosphorylation, methylation and ubiquitylation.

Indexed as

Protein Processing, Post-TranslationalAmino Acid SequenceAsparagineCell Line, TumorHumansHydroxylationHypoxia-Inducible Factor 1, alpha SubunitKineticsMass SpectrometryMethylationMixed Function OxygenasesPhosphorylationProtein BindingRepressor ProteinsSignal TransductionTankyrasesAsparagineHIF1AN protein, humanHIF1A protein, humanHypoxia-Inducible Factor 1, alpha SubunitMixed Function OxygenasesRepressor ProteinsTankyrasesTNKS2 protein, humanTRPV3 protein, humanTRPV Cation Channelsaffinity proteomicsfactor-inhibiting-HIFhydroxylationmass spectrometryPost-translational modificationssignal transductionSILAC

Identifiers

PMID32759169
PMCPMC7664127
OpenAlexW3048346310

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.